Sequential dynamic gadolinium magnetic resonance perfusion-weighted imaging: Effects on transit time and cerebral blood volume measurements

Acta Radiologica

Volumn 47, Issue 10, 2006, Pages 1079-1084

  Griffiths, P D ^a   Pandya, H ^a   Wilkinson, I D ^a   Hoggard, N ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Brain; CNS; MR imaging; MR perfusion

Indexed keywords

BLOOD; BRAIN; NEUROLOGY; PATIENT MONITORING; TIME MEASUREMENT; VOLUMETRIC ANALYSIS;

GADOLINIUM CHELATE; GADOLINIUM PERFUSION; MR PERFUSION; SEQUENTIAL STUDIES;

MAGNETIC RESONANCE IMAGING;

CONTRAST MEDIUM; GADOBUTROL; GADOLINIUM PENTETATE; ORGANOMETALLIC COMPOUND;

AGED; ARTICLE; BLOOD VOLUME; BRAIN CIRCULATION; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; TIME;

AGED; BLOOD VOLUME DETERMINATION; CEREBROVASCULAR CIRCULATION; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; TIME FACTORS;

EID: 33751550310     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1080/02841850600990292     Document Type: Article

References (10)

1. Calamante F, Gadian DG, Connelly A. Delay and dispersion effects in dynamic-susceptibility-contrast MRI: simulations using singular value decomposition. Magn Reson Med 2000;44:466-73.
2. Copen WA, Sorensen AG. Perfusion weighted MRI in stroke. In: Davis S, Fisher M, Warach S, editors. Magnetic resonance imaging in stroke. Cambridge: Cambridge University Press; 2003.
3. Griffiths PD, Gaines P, Cleveland T, Venables G, Beard J, Wilkinson ID. The assessment of cerebral hemodynamics and vascular reserve in patients with symptomatic carotid occlusion; an integrated approach using MR. Neuroradiology 2005;47:175-82.
4. Griffiths PD, Wilkinson ID, Wels T, Hoggard N. Brain MR perfusion imaging in humans. Acta Radiol 2001;42:555-9.
5. Kassner A, Annesley DJ, Zhu XP, Li KL, Kamaly-Asl ID, Watson Y, et al. Abnormalities of the contrast recirculation phase in cerebral tumours demonstrated using dynamic susceptibility contrast-enhanced imaging: a possible marker of vascular tortuosity. J. Magn Reson Imaging 2000;11:103-13.
6. Levin JM, Kaufman MJ, Ross MH, Mendelson JH, Maas LC, Cohen BM, et al. Sequential dynamic susceptibility contrast MR experiments in human brain: residual contrast agent effect, steady state and haemodynamic perturbation. Magn Res Med 1995;34:655-63.
7. Levin JM, Wald LL, Kaufman MJ, Ross MH, Maas LC, Renshaw PF. T1 effects in sequential dynamic susceptibility contrast experiments. J Magn Reson 1998;130:292-5.
8. Marstrand JR, Rostrup E, Rosenbaum S, Garde E, Larsson H. Cerebral hemodynamic changes measured by gradient-echo or spin-echo bolus tracking and its correlation to changes in ICA blood flow measured by phase-mapping MRI. J Magn Reson Imaging 2001;14:391-400.
9. Moore DF, Altarescu G, Herscovitch P, Schiffmann R. Enzyme replacement reverse abnormal cerebrovascular responses in Fabry disease. BMC Neurol 2002;18:2-4.
10. Runge VM, Kirsch JE, Wells JW, Dunworth JN, Hilaire L, Woolfolk CE. Repeat cerebral blood volume assessment with first-pass MR imaging. J Magn Reson Imaging 1994;4:457-61.